Pro Medicus Limited (ASX:PME) is a Melbourne-based software owner and developer, licensing products to large US hospitals and Australian radiology clinics. The company has offices in Richmond, Victoria, Berlin, Germany and in the United States.
Is the Pro Medicus Limited (ASX:PME) share price undervalued? Here are 3 reasons you might want to consider PME shares.
The Macquarie Group Ltd (ASX:MQG) share price has fallen 9.5% since the start of 2025. It’s probably worth asking, ‘is the MQG share price in the money?’
Want to value the Pro Medicus Limited (ASX:PME) share price? Here are 6 key metrics you need to consider.
The Pro Medicus Limited (ASX:PME) share price is down around 7.2% since the start of 2025. It’s probably worth asking, ‘is the PME share price top value?’
The Sonic Healthcare Ltd (ASX:SHL) share price is down 6.2% since the start of 2025. It’s probably worth asking, ‘is the SHL share price undervalued?’
Is the Pro Medicus Limited (ASX:PME) share price cheap? Here are 3 reasons you might want to consider PME shares.
The Pro Medicus Ltd (ASX:PME) share price is under the spotlight after the ASX healthcare share announced another big win in the US.
The Pro Medicus Limited (ASX:PME) share price is up 0.4% since the start of 2025. It’s probably worth asking, ‘is the PME share price good value?’
I own Pro Medicus Ltd (ASX: PME) shares, Resmed CDI (ASX: RMD) shares and Telix Pharmaceuticals Ltd (ASX: TLX) shares. This article explains why I own PME, RMD and TLX.
